Table 4. Comparison of the incidence and... | American Society of Hematology

Table 4.

Comparison of the incidence and outcome of the retinoic acid syndrome (RAS) in other reports

Study	No. of Patients	Induction	Incidence (%)	Mortality (%)^4-150 of Patients With RAS	Mortality (%)^4-151 of All Treated Patients
Vahdat⁶	78	ATRA	27	29	8
Wiley¹⁵	22	ATRA + steroids	9	50	5
Avvisati¹⁷	20	ATRA + chemo	10	0	0
Mandelli¹⁸	240	ATRA + chemo	3	17	0.4
Asou¹⁹	196	ATRA ± chemo	6	9	0.5
De Botton¹³	413	ATRA ± chemo	15	8	1
Tallman²	167	ATRA	26	5	1

Study	No. of Patients	Induction	Incidence (%)	Mortality (%)^4-150 of Patients With RAS	Mortality (%)^4-151 of All Treated Patients
Vahdat⁶	78	ATRA	27	29	8
Wiley¹⁵	22	ATRA + steroids	9	50	5
Avvisati¹⁷	20	ATRA + chemo	10	0	0
Mandelli¹⁸	240	ATRA + chemo	3	17	0.4
Asou¹⁹	196	ATRA ± chemo	6	9	0.5
De Botton¹³	413	ATRA ± chemo	15	8	1
Tallman²	167	ATRA	26	5	1

Percentage of patients with RAS with death attributable to RAS.

Percentage of all treated patients with death attributable to RAS.